Invivyd, Inc. (IVVD)
NASDAQ: IVVD · Real-Time Price · USD
2.450
0.00 (0.00%)
At close: Jan 16, 2026, 4:00 PM EST
2.400
-0.050 (-2.04%)
Pre-market: Jan 20, 2026, 7:38 AM EST
Invivyd Market Cap
Invivyd has a market cap or net worth of $690.87 million as of January 20, 2026. Its market cap has increased by 1,203.48% in one year.
Market Cap
690.87M
Enterprise Value
608.58M
1-Year Change
1,203.48%
Ranking
Category
Stock Price
$2.45
Market Cap Chart
Since August 6, 2021, Invivyd's market cap has decreased from $2.27B to $690.87M, a decrease of -69.51%. That is a compound annual growth rate of -23.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 690.87M | 0.93% |
| Dec 31, 2025 | 684.49M | 1,191.45% |
| Dec 31, 2024 | 53.00M | -87.78% |
| Dec 29, 2023 | 433.85M | 165.40% |
| Dec 30, 2022 | 163.47M | -79.76% |
| Dec 31, 2021 | 807.69M | -64.36% |
| Aug 6, 2021 | 2.27B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |